Basic & Clinical Medicine ›› 2016, Vol. 36 ›› Issue (1): 112-115.

Previous Articles     Next Articles

The role of AXL in tumor metastasis and drug resistance and strategy in anti-tumor therapies

  

  • Received:2015-03-23 Revised:2015-07-20 Online:2016-01-05 Published:2015-12-29

Abstract: The receptor tyrosine kinase (RTK) AXL is over expressed in multiple tumor cells and mediates the metastasis and drug resistance of tumor cells through a variety of signaling pathways, especially form positive feedback loops with EMT, therefore has become a new tumor therapeutic target. By inhibiting the expression of AXL can effectively reverse EMT and tumor metastasis and drug-resistance.

Key words: Key words: AXL, cancer cell, metastasis, invasion, drug resistance

CLC Number: